Upcoming innovations in lung cancer immunotherapy: Focus on immune checkpoint inhibitors

Sandrine Aspeslagh; Aurélien Marabelle; Jean Charles Soria; Jean Pierre Armand

doi:10.3978/j.issn.2304-3865.2015.12.06

Upcoming innovations in lung cancer immunotherapy: Focus on immune checkpoint inhibitors

Sandrine Aspeslagh, Aurélien Marabelle, Jean Charles Soria, Jean Pierre Armand

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

7 Citations (Scopus)

Résumé

For decades, immunotherapy strategies have failed to succeed in lung cancer. However, the recent success of immune checkpoint inhibitors and the progress in the understanding of the immunobiology of lung cancer have changed this paradigm. Here we review ongoing clinical trials and recent results obtained with these novel lung cancer immunotherapies.

langue originale	Anglais
Numéro d'article	48
journal	Chinese Clinical Oncology
Volume	4
Numéro de publication	4
Les DOIs	https://doi.org/10.3978/j.issn.2304-3865.2015.12.06
état	Publié - 1 janv. 2015
Modification externe	Oui

Accès au document

10.3978/j.issn.2304-3865.2015.12.06

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{4f5b2756826e4a69a838e540b5f5de18,

title = "Upcoming innovations in lung cancer immunotherapy: Focus on immune checkpoint inhibitors",

abstract = "For decades, immunotherapy strategies have failed to succeed in lung cancer. However, the recent success of immune checkpoint inhibitors and the progress in the understanding of the immunobiology of lung cancer have changed this paradigm. Here we review ongoing clinical trials and recent results obtained with these novel lung cancer immunotherapies.",

keywords = "Immune checkpoint inhibitors, Immunotherapy, Lung cancer, Vaccines",

author = "Sandrine Aspeslagh and Aur{\'e}lien Marabelle and Soria, {Jean Charles} and Armand, {Jean Pierre}",

note = "Publisher Copyright: {\textcopyright} Chinese Clinical Oncology.",

year = "2015",

month = jan,

day = "1",

doi = "10.3978/j.issn.2304-3865.2015.12.06",

language = "English",

volume = "4",

journal = "Chinese Clinical Oncology",

issn = "2304-3865",

number = "4",

}

TY - JOUR

T1 - Upcoming innovations in lung cancer immunotherapy

T2 - Focus on immune checkpoint inhibitors

AU - Aspeslagh, Sandrine

AU - Marabelle, Aurélien

AU - Soria, Jean Charles

AU - Armand, Jean Pierre

N1 - Publisher Copyright: © Chinese Clinical Oncology.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - For decades, immunotherapy strategies have failed to succeed in lung cancer. However, the recent success of immune checkpoint inhibitors and the progress in the understanding of the immunobiology of lung cancer have changed this paradigm. Here we review ongoing clinical trials and recent results obtained with these novel lung cancer immunotherapies.

AB - For decades, immunotherapy strategies have failed to succeed in lung cancer. However, the recent success of immune checkpoint inhibitors and the progress in the understanding of the immunobiology of lung cancer have changed this paradigm. Here we review ongoing clinical trials and recent results obtained with these novel lung cancer immunotherapies.

KW - Immune checkpoint inhibitors

KW - Immunotherapy

KW - Lung cancer

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84960123997&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2304-3865.2015.12.06

DO - 10.3978/j.issn.2304-3865.2015.12.06

M3 - Review article

C2 - 26730760

AN - SCOPUS:84960123997

SN - 2304-3865

VL - 4

JO - Chinese Clinical Oncology

JF - Chinese Clinical Oncology

IS - 4

M1 - 48

ER -